A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research ...
Several reports about the development of the next-generation Mazda MX-5 Miata have already emerged, but concrete details ...
Lotus hits the reset button as gas engines are back in play and the EV-only focus is history; PHEVs will play a big role ...
Gene editing can repair a DNA error in mice that causes Dravet syndrome, a rare, incurable, and potentially deadly form of ...
The Ford Maverick's marriage of truck design to some distinctly car-like aspects may broaden its appeal, but that doesn't ...
Following government scrutiny of its billing practices, nursing home giant PACS Group (NYSE: PACS) is entering a new phase of ...
The disappearance and suspected abduction of Nancy Guthrie reached its 100th day on May 11 as law enforcement continues to search for clues as to her whereabouts.
Proven, Hands-On Training Model Drives Consistency, Team Confidence, and Client Outcomes Across National Footprint ...
LenioBio GmbH, a TechBio company commercializing its ALiCE® cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscience Corporation. The collaboration will ...
The boom is real. The ambition is bigger. When the Robbie Williams biopic “Better Man” needed to recreate Stoke-on-Trent – a ...
Delvinia founder and CEO Adam Froman on why Canadian IP needs a rethink. Adam Froman is the founder and CEO of Delvinia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results